GSK Antibody Appears Effective In Older COVID-19 Patients

Otilimab Targets Cytokine Prevalent In Elderly

 
• By Alaric DeArment

With elderly patients disproportionately facing hospitalization and death from COVID-19, success in the clinic would create an important market for the drug.

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
Otilimab targets GM-CSF, a cytokine shown to be prevalent in COVID-19 patients 70 and older • Source: Shutterstock

More from R&D

More from Scrip